Liquid biopsy in breast cancer: A comprehensive review

S Alimirzaie, M Bagherzadeh, MR Akbari - Clinical genetics, 2019 - Wiley Online Library
Breast cancer is the most common cancer among women worldwide. Due to its complexity in
nature, effective breast cancer treatment can encounter many challenges. Traditional …

Molecular classification of breast carcinoma: from traditional, old-fashioned way to a new age, and a new way

N Eliyatkın, E Yalçın, B Zengel… - The journal of breast …, 2015 - pmc.ncbi.nlm.nih.gov
Breast carcinoma comprises a group of diseases with specific clinical, histopathologic and
molecular properties. Traditional classification use morphology to divide tumors into …

Characterizing the replicability of cell types defined by single cell RNA-sequencing data using MetaNeighbor

M Crow, A Paul, S Ballouz, ZJ Huang, J Gillis - Nature communications, 2018 - nature.com
Single-cell RNA-sequencing (scRNA-seq) technology provides a new avenue to discover
and characterize cell types; however, the experiment-specific technical biases and analytic …

A comparison of PAM50 intrinsic subty** with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor–positive breast cancer

TO Nielsen, JS Parker, S Leung, D Voduc… - Clinical cancer …, 2010 - aacrjournals.org
Purpose: To compare clinical, immunohistochemical (IHC), and gene expression models of
prognosis applicable to formalin-fixed, paraffin-embedded blocks in a large series of …

Validation of cluster analysis results on validation data: A systematic framework

T Ullmann, C Hennig… - … Reviews: Data Mining …, 2022 - Wiley Online Library
Cluster analysis refers to a wide range of data analytic techniques for class discovery and is
popular in many application fields. To assess the quality of a clustering result, different …

Clinical and Pathologic Characteristics of Patients With BRCA-Positive and BRCA-Negative Breast Cancer

DP Atchley, CT Albarracin, A Lopez… - Journal of Clinical …, 2008 - ascopubs.org
Purpose Mutations in the BRCA1 and BRCA2 genes confer greater risk of develo** breast
cancer. We determined whether tumor pathologic features and clinical features differ in …

How basal are triple‐negative breast cancers?

F Bertucci, P Finetti, N Cervera, B Esterni… - … journal of Cancer, 2008 - Wiley Online Library
The basal molecular subtype of breast cancer (BC) is defined by the mRNA expression
pattern of an intrinsic∼ 500‐gene set. It is the most homogeneous subtype in transcriptional …

Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling

C Gewinner, ZC Wang, A Richardson… - Cancer cell, 2009 - cell.com
We report that knocking down the expression of inositol polyphosphate 4-phosphatase type
II (INPP4B) in human epithelial cells, like knockdown of PTEN, resulted in enhanced Akt …

A three-gene model to robustly identify breast cancer molecular subtypes

B Haibe-Kains, C Desmedt, S Loi… - Journal of the …, 2012 - academic.oup.com
Abstract Background Single sample predictors (SSPs) and Subtype classification models
(SCMs) are gene expression–based classifiers used to identify the four primary molecular …

What is triple-negative breast cancer?

WJ Irvin Jr, LA Carey - European journal of cancer, 2008 - Elsevier
Triple-negative (ER-negative, PR-negative, HER2/neu not overexpressed) breast cancer
has distinct clinical and pathologic features, and is a clinical problem because of its …